Patents-Review.com
🔗 Permalink
Inventor profile of:

Michael D. Bartberger

City:

Sherman Oaks, California

Country:

United States

Published Applications:

28

Last publication date:

2026-03-19

Top Assignees for applications by Michael D. Bartberger

The entities that hold a legal rights for patent applications filed by inventor Bartberger Michael D.:

Recent patent applications by Bartberger Michael D.

Michael D. Bartberger from Sherman Oaks, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-19
US20260078091A1
Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

 #2 | 2024-09-12
US20240300892A1
Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

 #3 | 2023-04-13
US20230116602A1
Chemistry; metallurgy

MCL1 INHIBITORS AND USES THEREOF

 #4 | 2022-07-21
US20220227738A1
Chemistry; metallurgy

KRAS G12C INHIBITORS AND USES THEREOF

 #5 | 2022-06-23
US20220194949A1
Chemistry; metallurgy

PRMT5 INHIBITORS AND USES THEREOF

 #6 | 2022-06-02
US20220169611A1
Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

 #7 | 2022-04-07
US20220106325A1
Chemistry; metallurgy

CDK INHIBITORS AND USES THEREOF

 #8 | 2022-01-06
US20220002294A1
Chemistry; metallurgy

ERK INHIBITORS AND USES THEREOF

 #9 | 2021-06-17
US20210179560A1
Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

 #10 | 2020-10-01
US20200308145A1
Chemistry; metallurgy

Benzimidazole derivatives and their uses

 #11 | 2020-01-30
US20200030324A1
Human necessities

KRAS G12C inhibitors and methods of using the same

 #12 | 2019-11-07
US20190336514A1
Human necessities

KRAS G12C inhibitors and methods of using the same

 #13 | 2019-02-28
US20190062276A1
Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

 #14 | 2018-12-13
US20180354918A1
Chemistry; metallurgy

CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer

 #15 | 2017-05-25
US20170144971A1
Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

 #16 | 2016-05-19
US20160137667A1
Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

 #17 | 2016-01-07
US20160002185A1
Chemistry; metallurgy

CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER

 #18 | 2014-10-23
US20140315895A1
Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

 #19 | 2014-08-21
US20140235629A1
Chemistry; metallurgy

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

 #20 | 2012-01-12
US20120010256A1
Chemistry; metallurgy

Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1

 #21 | 2011-04-07
US20110082107A1
Chemistry; metallurgy

INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1

 #22 | 2010-09-02
US20100222338A1
Chemistry; metallurgy

Beta-Secretase modulators and methods of use

 #23 | 2008-02-21
US20080045503A1
Chemistry; metallurgy

Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1

 #24 | 2008-01-24
US20080021022A1
Chemistry; metallurgy

Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1

 #25 | 2007-12-06
US20070281938A1
Chemistry; metallurgy

Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1

 #26 | 2007-08-23
US20070197598A1
Chemistry; metallurgy

Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1

 #27 | 2007-08-09
US20070185144A1
Chemistry; metallurgy

Beta-secretase modulators and methods of use

 #28 | 2006-06-29
US20060142357A1
Chemistry; metallurgy

Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
InventorID:

880969 ⎘